CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Oerth Bio
Oerth Bio logo

Oerth Bio

Oerth Bio develops targeted protein degraders for agriculture and novel human therapeutics.

Durham, NC, US🇺🇸
Founded
2019
Overview
Compare
Fundraising
Employees
Library

Founded with the mission to revolutionize agriculture and human health, Oerth Bio leverages Arvinas' PROTAC® protein degrader technology to develop targeted solutions for both sectors. The company focuses on creating sustainable agricultural practices by enhancing crop protection and plant health, addressing issues such as abiotic stress. Additionally, Oerth Bio is expanding its technology to develop novel human therapeutics for cardiovascular, oncological, and gynecological diseases.

Notable affiliations include Arvinas, a pioneer in protein degradation technology. Oerth Bio has achieved significant milestones in applying this technology to agriculture, promising to reduce the environmental footprint of farming while increasing crop resilience and quality. Their impact is marked by the potential to transform global food systems and improve human health through innovative biotechnological solutions.

Oerth Bio - Similar Companies

76Bio logo

76Bio

76bio.com

Arvinas logo

Arvinas

arvinas.com

TerMir logo

TerMir

Biotheryx logo

Biotheryx

Oerth Bio - Quick Facts

Who are Oerth Bio's competitors?

Companies similar to Oerth Bio include 76Bio, Arvinas, TerMir and Biotheryx.

When was Oerth Bio founded?

Oerth Bio was founded in 2019.

Where is Oerth Bio's headquarters located?

Oerth Bio's headquarters is located in Durham, NC, US.

When was Oerth Bio's last funding round?

Oerth Bio's most recent funding round was for $55M (USD) in February 2020.

How much disclosed funding has Oerth Bio raised?

As of Feb 27, 2020, Oerth Bio has disclosed funding of $55M (USD). Undisclosed round amounts are excluded.

Oerth Bio - Classification

Ownership
  • Venture-backed
Technology
  • Biotech
Geographic Exposure
  • Global

How many employees does Oerth Bio have?

Oerth Bio has 50 employees as of Feb 4, 2024.

Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Crop Protection
  • Therapeutics
Tags
  • AgTech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified

biotheryx.com

AgroSpheres logo

AgroSpheres

agrospheres.com

AgBiome logo

AgBiome

agbiome.com

EvoAktiv logo

EvoAktiv

evoagtec.com

Ascribe Bioscience logo

Ascribe Bioscience

ascribebio.com

Avilar Therapeutics logo

Avilar Therapeutics

avilar-tx.com

Biodel logo

Biodel

biodelag.com

EpiBiologics logo

EpiBiologics

epibiologics.com

Origami Therapeutics, Inc. logo

Origami Therapeutics, Inc.

Agradis logo

Agradis

Orthogonal Thinker logo

Orthogonal Thinker

Agragene logo

Agragene

agragene.com